Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?
Preliminary studies suggest that a pentavalent group B streptococcus conjugate vaccine, given in a single dose at 32-34 weeks gestation, would prevent approximately 90% of early and late onset neonatal and most postpartum maternal group B streptococcus infections.
Gilbert
G L
GL
Center for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, and National Center for Immunization Research and Surveillance, University of Sydney, Sydney, Australia. ggilbert@mail.usyd.edu.au
D019072:Antibiotic Prophylaxis; D005260:Female; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D011247:Pregnancy; D013290:Streptococcal Infections / Q000517:prevention & control*; D022541:Streptococcal Vaccines / Q000276:immunology*; D013292:Streptococcus agalactiae / Q000276:immunology*; D018074:Vaccines, Conjugate / Q000276:immunology
D022541:Streptococcal Vaccines; D018074:Vaccines, Conjugate